1 / 6

Global Myocardial Infarction Market, Size, Share, Analysis Report & Forecast

The global myocardial infarction market is anticipated to grow at a modest CAGR of around 6.6% during the forecast period.

alfahadkhan2510
Download Presentation

Global Myocardial Infarction Market, Size, Share, Analysis Report & Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Myocardial Infarction Market, Size, Share, Analysis Report & Forecast to 2026 Global Myocardial Infarction Market Size, Growth Analysis Report, Forecast to 2027 Global Myocardial Infarction Market Size, Growth Analysis Report, Forecast to 2027 Global Myocardial Infarction Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Myocardial Infarction Market Trends Segmentation, Outlook, Industry Report to 2021-2027 | The global myocardial infarction market is anticipated to grow at a modest CAGR of around 6.6% during the forecast period. The global myocardial infarction market is primarily driven by the increasing incidence and prevalence rate of chronic diseases, such as diabetes and hypertension along with unhealthy lifestyle changes such as suboptimal diets, excessive consumption of tobacco consumption and alcohol, and sedentary lifestyles. According to WHO, there is an increased risk of myocardial infarction in individuals with smoking habits. The global rise in smokers has increased the risk of heart diseases, it is anticipated to create demand for the myocardial infarction market. According to the Centers for Disease Control and Prevention (CDC), in 2018, nearly 14 of every 100 US adults aged 18 years or older (13.7%) smoked cigarettes. This means an estimated 34.2 million adults in the US currently smoke cigarettes. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/myocardial- infarction-market

  2. The global myocardial infarction market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into non-ST segment elevation myocardial infarction (NSTEMI) heart attacks, ST-segment elevation myocardial infarction (STEMI) heart attacks, and silent heart attacks. Among these, STEMI held the highest market share in 2020 and is estimated to grow a significant CAGR during the forecast period. STEMI is the most common type of heart attack among all types. The commonly used treatment for STEMI includes percutaneous coronary intervention (PCI), a term that consists of both angioplasty and stenting; clot-busting medication; and coronary artery bypass graft surgery (CABG). Based on the device, the market is segmented into the left ventricular assist device, pacemaker, catheter, implantable cardioverter defibrillator, and others (graft and stent). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT scan), echocardiography, and others. On the basis of treatment, the market is bifurcated into medication and procedure. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes. A https://www.omrglobal.com/industry-reports/myocardial-infarction-market Full Report of Global Myocardial Infarction Market is Available at: Geographically, the global myocardial infarction market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia- Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, the Asia-Pacific market is anticipated to showcase the highest CAGR during the forecast period. Increasing cases related to CVD and heart attack, increasing healthcare infrastructure, and increasing unhealthy lifestyles among people in the region are some of the major factors for the growth of the market in the region. The increasing medical tourism and improving healthcare infrastructure are also contributing significantly to the growth of the myocardial infarction market in the region. The developing economies of Asia-Pacific, especially China, Japan, and India are investing significantly in the development of innovative therapeutic and medical devices. Global Myocardial Infarction Market– Segmentation By Type •Non-St-Elevation Myocardial Infarction (NSTEMI) •St-Elevation Myocardial Infarction (STEMI) Heart Attack •Silent Heart Attack By Device •Left Ventricular Assist Device •Pacemaker

  3. •Catheters •Implantable Cardioverter Defibrillator •Others By Diagnosis •Electrocardiography (ECG) •Chest X-Ray •Computed Tomography (CT scan) •Echocardiography •Others (Blood Test) By Treatment •Medication •Analgesics •Thrombolytic •Anti-Platelet Agents •Glycoprotein LIB/LIB Inhibitors •Others (Beta-Adrenergic Blockers and Angiotensin-Receptor Blockers) •Surgery •Angioplasty •Coronary Artery Bypass Grafting (CABG) •Heart Transplant By End-Users •Hospitals and Clinics •Ambulatory Surgical Centers •Research Institutes Global Myocardial Infarction Market – Segmentation by Region North America •United States •Canada Europe •Germany •United Kingdom •France

  4. •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World Company Profiles •Abbott Laboratories •advanceCOR GmbH. •AstraZeneca PLC •Athersys, Inc. •Bayer AG •BioVascular Inc. •Boehringer Ingelheim International GmbH •Boston Scientific Corp. •Bristol-Myers Squibb, Co. •Caladrius Biosciences, Inc. •Capricor Therapeutics Inc. •CSL Behring •Eli Lilly And Co. •GlaxoSmithKline plc. •GNT Pharma Co., Ltd. •Johnson & Johnson Services Inc.

  5. •Koninklijke Philips N.V. •Medtronic Plc •Merck KGaA •Mesoblast Ltd •Mylan N.V. •Novartis AG •NeuroVive Pharmaceutical AB •Osiris Therapeutics Inc. •Pfizer Inc. •PledPharma AB •Portola Pharmaceutical Inc. •Sanofi SA •Siemens AG •Teva Pharmaceutical Industries Ltd. •Ventrix Inc. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/myocardial-infarction-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact:

  6. Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related